nodes	percent_of_prediction	percent_of_DWPC	metapath
Risedronate—Paget's disease of bone—sarcoma	0.859	1	CtDrD
Risedronate—PTGS2—Etoposide—sarcoma	0.016	1	CbGbCtD
Risedronate—FDPS—periosteum—sarcoma	0.00854	0.188	CbGeAlD
Risedronate—PTGS2—periosteum—sarcoma	0.00327	0.072	CbGeAlD
Risedronate—PTGS2—leg—sarcoma	0.00261	0.0574	CbGeAlD
Risedronate—PTGS2—hindlimb—sarcoma	0.00233	0.0512	CbGeAlD
Risedronate—PTGS2—cartilage tissue—sarcoma	0.00229	0.0504	CbGeAlD
Risedronate—PTGS2—appendage—sarcoma	0.002	0.044	CbGeAlD
Risedronate—FDPS—myometrium—sarcoma	0.0018	0.0396	CbGeAlD
Risedronate—FDPS—seminal vesicle—sarcoma	0.00163	0.0358	CbGeAlD
Risedronate—FDPS—hematopoietic system—sarcoma	0.00155	0.034	CbGeAlD
Risedronate—FDPS—connective tissue—sarcoma	0.00149	0.0327	CbGeAlD
Risedronate—FDPS—smooth muscle tissue—sarcoma	0.00136	0.0299	CbGeAlD
Risedronate—FDPS—skin of body—sarcoma	0.00134	0.0296	CbGeAlD
Risedronate—PTGS2—endothelium—sarcoma	0.00121	0.0265	CbGeAlD
Risedronate—FDPS—cardiac atrium—sarcoma	0.00117	0.0258	CbGeAlD
Risedronate—FDPS—uterus—sarcoma	0.00117	0.0257	CbGeAlD
Risedronate—FDPS—lymphoid tissue—sarcoma	0.00109	0.0239	CbGeAlD
Risedronate—FDPS—tendon—sarcoma	0.00102	0.0225	CbGeAlD
Risedronate—FDPS—bone marrow—sarcoma	0.000991	0.0218	CbGeAlD
Risedronate—FDPS—testis—sarcoma	0.000847	0.0186	CbGeAlD
Risedronate—FDPS—liver—sarcoma	0.000801	0.0176	CbGeAlD
Risedronate—PTGS2—myometrium—sarcoma	0.00069	0.0152	CbGeAlD
Risedronate—PTGS2—embryo—sarcoma	0.000664	0.0146	CbGeAlD
Risedronate—PTGS2—seminal vesicle—sarcoma	0.000623	0.0137	CbGeAlD
Risedronate—FDPS—lymph node—sarcoma	0.000614	0.0135	CbGeAlD
Risedronate—PTGS2—hematopoietic system—sarcoma	0.000592	0.013	CbGeAlD
Risedronate—PTGS2—connective tissue—sarcoma	0.00057	0.0125	CbGeAlD
Risedronate—PTGS2—smooth muscle tissue—sarcoma	0.000522	0.0115	CbGeAlD
Risedronate—PTGS2—skin of body—sarcoma	0.000515	0.0113	CbGeAlD
Risedronate—PTGS2—uterus—sarcoma	0.000447	0.00984	CbGeAlD
Risedronate—PTGS2—lymphoid tissue—sarcoma	0.000417	0.00917	CbGeAlD
Risedronate—PTGS2—tendon—sarcoma	0.000392	0.00862	CbGeAlD
Risedronate—PTGS2—bone marrow—sarcoma	0.00038	0.00835	CbGeAlD
Risedronate—PTGS2—liver—sarcoma	0.000307	0.00675	CbGeAlD
Risedronate—PTGS2—lymph node—sarcoma	0.000235	0.00518	CbGeAlD
Risedronate—Osteoarthritis—Epirubicin—sarcoma	0.000159	0.00199	CcSEcCtD
Risedronate—Pain in extremity—Epirubicin—sarcoma	0.000159	0.00199	CcSEcCtD
Risedronate—Gastrointestinal pain—Thiotepa—sarcoma	0.000159	0.00198	CcSEcCtD
Risedronate—Anaemia—Etoposide—sarcoma	0.000158	0.00197	CcSEcCtD
Risedronate—Gastrointestinal pain—Dactinomycin—sarcoma	0.000158	0.00197	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Vincristine—sarcoma	0.000157	0.00196	CcSEcCtD
Risedronate—Insomnia—Vincristine—sarcoma	0.000156	0.00195	CcSEcCtD
Risedronate—Paraesthesia—Vincristine—sarcoma	0.000155	0.00193	CcSEcCtD
Risedronate—Urticaria—Thiotepa—sarcoma	0.000154	0.00193	CcSEcCtD
Risedronate—Vertigo—Etoposide—sarcoma	0.000153	0.00192	CcSEcCtD
Risedronate—Body temperature increased—Thiotepa—sarcoma	0.000153	0.00192	CcSEcCtD
Risedronate—Abdominal pain—Thiotepa—sarcoma	0.000153	0.00192	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Mitoxantrone—sarcoma	0.000153	0.00191	CcSEcCtD
Risedronate—Body temperature increased—Dactinomycin—sarcoma	0.000152	0.0019	CcSEcCtD
Risedronate—Abdominal pain—Dactinomycin—sarcoma	0.000152	0.0019	CcSEcCtD
Risedronate—Paraesthesia—Mitoxantrone—sarcoma	0.000151	0.00188	CcSEcCtD
Risedronate—Loss of consciousness—Etoposide—sarcoma	0.00015	0.00188	CcSEcCtD
Risedronate—Dyspnoea—Mitoxantrone—sarcoma	0.000149	0.00187	CcSEcCtD
Risedronate—Cough—Etoposide—sarcoma	0.000149	0.00186	CcSEcCtD
Risedronate—Gastrointestinal disorder—Vincristine—sarcoma	0.000149	0.00186	CcSEcCtD
Risedronate—Fatigue—Vincristine—sarcoma	0.000148	0.00185	CcSEcCtD
Risedronate—Dyspepsia—Mitoxantrone—sarcoma	0.000148	0.00184	CcSEcCtD
Risedronate—Hypertension—Etoposide—sarcoma	0.000147	0.00184	CcSEcCtD
Risedronate—Pain—Vincristine—sarcoma	0.000147	0.00184	CcSEcCtD
Risedronate—Constipation—Vincristine—sarcoma	0.000147	0.00184	CcSEcCtD
Risedronate—Pain in extremity—Doxorubicin—sarcoma	0.000147	0.00184	CcSEcCtD
Risedronate—Osteoarthritis—Doxorubicin—sarcoma	0.000147	0.00184	CcSEcCtD
Risedronate—Liver function test abnormal—Epirubicin—sarcoma	0.000147	0.00183	CcSEcCtD
Risedronate—Chest pain—Etoposide—sarcoma	0.000145	0.00182	CcSEcCtD
Risedronate—Abdominal pain upper—Epirubicin—sarcoma	0.000145	0.00182	CcSEcCtD
Risedronate—Fatigue—Mitoxantrone—sarcoma	0.000145	0.00181	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Etoposide—sarcoma	0.000144	0.00181	CcSEcCtD
Risedronate—Breast disorder—Epirubicin—sarcoma	0.000144	0.0018	CcSEcCtD
Risedronate—Constipation—Mitoxantrone—sarcoma	0.000143	0.00179	CcSEcCtD
Risedronate—Pain—Mitoxantrone—sarcoma	0.000143	0.00179	CcSEcCtD
Risedronate—Hypersensitivity—Thiotepa—sarcoma	0.000143	0.00179	CcSEcCtD
Risedronate—Nasopharyngitis—Epirubicin—sarcoma	0.000142	0.00178	CcSEcCtD
Risedronate—Hypersensitivity—Dactinomycin—sarcoma	0.000142	0.00177	CcSEcCtD
Risedronate—Gastrointestinal pain—Vincristine—sarcoma	0.000141	0.00176	CcSEcCtD
Risedronate—Gastritis—Epirubicin—sarcoma	0.000141	0.00176	CcSEcCtD
Risedronate—Muscular weakness—Epirubicin—sarcoma	0.00014	0.00175	CcSEcCtD
Risedronate—Asthenia—Thiotepa—sarcoma	0.000139	0.00174	CcSEcCtD
Risedronate—Infection—Etoposide—sarcoma	0.000139	0.00173	CcSEcCtD
Risedronate—Abdominal distension—Epirubicin—sarcoma	0.000138	0.00173	CcSEcCtD
Risedronate—Asthenia—Dactinomycin—sarcoma	0.000138	0.00173	CcSEcCtD
Risedronate—Asthma—Epirubicin—sarcoma	0.000137	0.00172	CcSEcCtD
Risedronate—Influenza—Epirubicin—sarcoma	0.000137	0.00172	CcSEcCtD
Risedronate—Pruritus—Thiotepa—sarcoma	0.000137	0.00172	CcSEcCtD
Risedronate—Gastrointestinal pain—Mitoxantrone—sarcoma	0.000137	0.00171	CcSEcCtD
Risedronate—Abdominal pain—Vincristine—sarcoma	0.000136	0.0017	CcSEcCtD
Risedronate—Body temperature increased—Vincristine—sarcoma	0.000136	0.0017	CcSEcCtD
Risedronate—Liver function test abnormal—Doxorubicin—sarcoma	0.000136	0.0017	CcSEcCtD
Risedronate—Skin disorder—Etoposide—sarcoma	0.000135	0.00169	CcSEcCtD
Risedronate—Abdominal pain upper—Doxorubicin—sarcoma	0.000134	0.00168	CcSEcCtD
Risedronate—Angina pectoris—Epirubicin—sarcoma	0.000134	0.00167	CcSEcCtD
Risedronate—Urticaria—Mitoxantrone—sarcoma	0.000133	0.00166	CcSEcCtD
Risedronate—Breast disorder—Doxorubicin—sarcoma	0.000133	0.00166	CcSEcCtD
Risedronate—Diarrhoea—Thiotepa—sarcoma	0.000133	0.00166	CcSEcCtD
Risedronate—Abdominal pain—Mitoxantrone—sarcoma	0.000133	0.00166	CcSEcCtD
Risedronate—Body temperature increased—Mitoxantrone—sarcoma	0.000133	0.00166	CcSEcCtD
Risedronate—Bronchitis—Epirubicin—sarcoma	0.000132	0.00165	CcSEcCtD
Risedronate—Diarrhoea—Dactinomycin—sarcoma	0.000132	0.00165	CcSEcCtD
Risedronate—Nasopharyngitis—Doxorubicin—sarcoma	0.000132	0.00164	CcSEcCtD
Risedronate—Gastritis—Doxorubicin—sarcoma	0.00013	0.00163	CcSEcCtD
Risedronate—Muscular weakness—Doxorubicin—sarcoma	0.00013	0.00162	CcSEcCtD
Risedronate—Dizziness—Thiotepa—sarcoma	0.000128	0.0016	CcSEcCtD
Risedronate—Abdominal distension—Doxorubicin—sarcoma	0.000128	0.0016	CcSEcCtD
Risedronate—Upper respiratory tract infection—Epirubicin—sarcoma	0.000128	0.0016	CcSEcCtD
Risedronate—Influenza—Doxorubicin—sarcoma	0.000127	0.00159	CcSEcCtD
Risedronate—Asthma—Doxorubicin—sarcoma	0.000127	0.00159	CcSEcCtD
Risedronate—Hypersensitivity—Vincristine—sarcoma	0.000127	0.00158	CcSEcCtD
Risedronate—Paraesthesia—Etoposide—sarcoma	0.000125	0.00156	CcSEcCtD
Risedronate—Dyspnoea—Etoposide—sarcoma	0.000124	0.00155	CcSEcCtD
Risedronate—Angina pectoris—Doxorubicin—sarcoma	0.000124	0.00155	CcSEcCtD
Risedronate—Hypersensitivity—Mitoxantrone—sarcoma	0.000123	0.00154	CcSEcCtD
Risedronate—Asthenia—Vincristine—sarcoma	0.000123	0.00154	CcSEcCtD
Risedronate—Vomiting—Thiotepa—sarcoma	0.000123	0.00154	CcSEcCtD
Risedronate—Pneumonia—Epirubicin—sarcoma	0.000123	0.00154	CcSEcCtD
Risedronate—Infestation NOS—Epirubicin—sarcoma	0.000123	0.00153	CcSEcCtD
Risedronate—Infestation—Epirubicin—sarcoma	0.000123	0.00153	CcSEcCtD
Risedronate—Vomiting—Dactinomycin—sarcoma	0.000122	0.00153	CcSEcCtD
Risedronate—Rash—Thiotepa—sarcoma	0.000122	0.00153	CcSEcCtD
Risedronate—Bronchitis—Doxorubicin—sarcoma	0.000122	0.00153	CcSEcCtD
Risedronate—Dermatitis—Thiotepa—sarcoma	0.000122	0.00153	CcSEcCtD
Risedronate—Headache—Thiotepa—sarcoma	0.000122	0.00152	CcSEcCtD
Risedronate—Rash—Dactinomycin—sarcoma	0.000121	0.00152	CcSEcCtD
Risedronate—Gastrointestinal disorder—Etoposide—sarcoma	0.00012	0.0015	CcSEcCtD
Risedronate—Asthenia—Mitoxantrone—sarcoma	0.00012	0.0015	CcSEcCtD
Risedronate—Fatigue—Etoposide—sarcoma	0.00012	0.0015	CcSEcCtD
Risedronate—Pain—Etoposide—sarcoma	0.000119	0.00149	CcSEcCtD
Risedronate—Constipation—Etoposide—sarcoma	0.000119	0.00149	CcSEcCtD
Risedronate—Conjunctivitis—Epirubicin—sarcoma	0.000119	0.00149	CcSEcCtD
Risedronate—Urinary tract infection—Epirubicin—sarcoma	0.000119	0.00149	CcSEcCtD
Risedronate—Upper respiratory tract infection—Doxorubicin—sarcoma	0.000118	0.00148	CcSEcCtD
Risedronate—Diarrhoea—Vincristine—sarcoma	0.000118	0.00147	CcSEcCtD
Risedronate—Hepatobiliary disease—Epirubicin—sarcoma	0.000116	0.00145	CcSEcCtD
Risedronate—Nausea—Thiotepa—sarcoma	0.000115	0.00144	CcSEcCtD
Risedronate—Sinusitis—Epirubicin—sarcoma	0.000115	0.00144	CcSEcCtD
Risedronate—Diarrhoea—Mitoxantrone—sarcoma	0.000115	0.00143	CcSEcCtD
Risedronate—Nausea—Dactinomycin—sarcoma	0.000114	0.00143	CcSEcCtD
Risedronate—Pneumonia—Doxorubicin—sarcoma	0.000114	0.00143	CcSEcCtD
Risedronate—Gastrointestinal pain—Etoposide—sarcoma	0.000114	0.00142	CcSEcCtD
Risedronate—Dizziness—Vincristine—sarcoma	0.000114	0.00142	CcSEcCtD
Risedronate—Infestation NOS—Doxorubicin—sarcoma	0.000113	0.00142	CcSEcCtD
Risedronate—Infestation—Doxorubicin—sarcoma	0.000113	0.00142	CcSEcCtD
Risedronate—Urticaria—Etoposide—sarcoma	0.000111	0.00138	CcSEcCtD
Risedronate—Haemoglobin—Epirubicin—sarcoma	0.000111	0.00138	CcSEcCtD
Risedronate—Rhinitis—Epirubicin—sarcoma	0.00011	0.00138	CcSEcCtD
Risedronate—Body temperature increased—Etoposide—sarcoma	0.00011	0.00138	CcSEcCtD
Risedronate—Abdominal pain—Etoposide—sarcoma	0.00011	0.00138	CcSEcCtD
Risedronate—Conjunctivitis—Doxorubicin—sarcoma	0.00011	0.00138	CcSEcCtD
Risedronate—Urinary tract infection—Doxorubicin—sarcoma	0.00011	0.00138	CcSEcCtD
Risedronate—Haemorrhage—Epirubicin—sarcoma	0.00011	0.00137	CcSEcCtD
Risedronate—Vomiting—Vincristine—sarcoma	0.000109	0.00137	CcSEcCtD
Risedronate—Pharyngitis—Epirubicin—sarcoma	0.000109	0.00136	CcSEcCtD
Risedronate—Urinary tract disorder—Epirubicin—sarcoma	0.000109	0.00136	CcSEcCtD
Risedronate—Rash—Vincristine—sarcoma	0.000109	0.00136	CcSEcCtD
Risedronate—Dermatitis—Vincristine—sarcoma	0.000108	0.00135	CcSEcCtD
Risedronate—Oedema peripheral—Epirubicin—sarcoma	0.000108	0.00135	CcSEcCtD
Risedronate—Connective tissue disorder—Epirubicin—sarcoma	0.000108	0.00135	CcSEcCtD
Risedronate—Urethral disorder—Epirubicin—sarcoma	0.000108	0.00135	CcSEcCtD
Risedronate—Headache—Vincristine—sarcoma	0.000108	0.00135	CcSEcCtD
Risedronate—Hepatobiliary disease—Doxorubicin—sarcoma	0.000107	0.00134	CcSEcCtD
Risedronate—Vomiting—Mitoxantrone—sarcoma	0.000107	0.00133	CcSEcCtD
Risedronate—Sinusitis—Doxorubicin—sarcoma	0.000106	0.00133	CcSEcCtD
Risedronate—Rash—Mitoxantrone—sarcoma	0.000106	0.00132	CcSEcCtD
Risedronate—Dermatitis—Mitoxantrone—sarcoma	0.000106	0.00132	CcSEcCtD
Risedronate—Headache—Mitoxantrone—sarcoma	0.000105	0.00131	CcSEcCtD
Risedronate—Eye disorder—Epirubicin—sarcoma	0.000103	0.00128	CcSEcCtD
Risedronate—Hypersensitivity—Etoposide—sarcoma	0.000103	0.00128	CcSEcCtD
Risedronate—Tinnitus—Epirubicin—sarcoma	0.000103	0.00128	CcSEcCtD
Risedronate—Haemoglobin—Doxorubicin—sarcoma	0.000102	0.00128	CcSEcCtD
Risedronate—Nausea—Vincristine—sarcoma	0.000102	0.00128	CcSEcCtD
Risedronate—Cardiac disorder—Epirubicin—sarcoma	0.000102	0.00128	CcSEcCtD
Risedronate—Rhinitis—Doxorubicin—sarcoma	0.000102	0.00128	CcSEcCtD
Risedronate—Haemorrhage—Doxorubicin—sarcoma	0.000102	0.00127	CcSEcCtD
Risedronate—Pharyngitis—Doxorubicin—sarcoma	0.000101	0.00126	CcSEcCtD
Risedronate—Urinary tract disorder—Doxorubicin—sarcoma	0.000101	0.00126	CcSEcCtD
Risedronate—Oedema peripheral—Doxorubicin—sarcoma	0.0001	0.00125	CcSEcCtD
Risedronate—Asthenia—Etoposide—sarcoma	0.0001	0.00125	CcSEcCtD
Risedronate—Connective tissue disorder—Doxorubicin—sarcoma	0.0001	0.00125	CcSEcCtD
Risedronate—Angiopathy—Epirubicin—sarcoma	9.98e-05	0.00125	CcSEcCtD
Risedronate—Urethral disorder—Doxorubicin—sarcoma	9.98e-05	0.00125	CcSEcCtD
Risedronate—Nausea—Mitoxantrone—sarcoma	9.96e-05	0.00124	CcSEcCtD
Risedronate—Immune system disorder—Epirubicin—sarcoma	9.94e-05	0.00124	CcSEcCtD
Risedronate—Mediastinal disorder—Epirubicin—sarcoma	9.91e-05	0.00124	CcSEcCtD
Risedronate—Pruritus—Etoposide—sarcoma	9.86e-05	0.00123	CcSEcCtD
Risedronate—Arrhythmia—Epirubicin—sarcoma	9.83e-05	0.00123	CcSEcCtD
Risedronate—Mental disorder—Epirubicin—sarcoma	9.64e-05	0.0012	CcSEcCtD
Risedronate—Malnutrition—Epirubicin—sarcoma	9.58e-05	0.0012	CcSEcCtD
Risedronate—Diarrhoea—Etoposide—sarcoma	9.54e-05	0.00119	CcSEcCtD
Risedronate—Eye disorder—Doxorubicin—sarcoma	9.51e-05	0.00119	CcSEcCtD
Risedronate—Tinnitus—Doxorubicin—sarcoma	9.49e-05	0.00119	CcSEcCtD
Risedronate—Cardiac disorder—Doxorubicin—sarcoma	9.45e-05	0.00118	CcSEcCtD
Risedronate—Flatulence—Epirubicin—sarcoma	9.44e-05	0.00118	CcSEcCtD
Risedronate—Back pain—Epirubicin—sarcoma	9.26e-05	0.00116	CcSEcCtD
Risedronate—Angiopathy—Doxorubicin—sarcoma	9.24e-05	0.00115	CcSEcCtD
Risedronate—Dizziness—Etoposide—sarcoma	9.22e-05	0.00115	CcSEcCtD
Risedronate—Muscle spasms—Epirubicin—sarcoma	9.21e-05	0.00115	CcSEcCtD
Risedronate—Immune system disorder—Doxorubicin—sarcoma	9.19e-05	0.00115	CcSEcCtD
Risedronate—Mediastinal disorder—Doxorubicin—sarcoma	9.17e-05	0.00115	CcSEcCtD
Risedronate—Arrhythmia—Doxorubicin—sarcoma	9.09e-05	0.00114	CcSEcCtD
Risedronate—Mental disorder—Doxorubicin—sarcoma	8.92e-05	0.00111	CcSEcCtD
Risedronate—Vomiting—Etoposide—sarcoma	8.87e-05	0.00111	CcSEcCtD
Risedronate—Malnutrition—Doxorubicin—sarcoma	8.86e-05	0.00111	CcSEcCtD
Risedronate—Anaemia—Epirubicin—sarcoma	8.85e-05	0.00111	CcSEcCtD
Risedronate—Rash—Etoposide—sarcoma	8.79e-05	0.0011	CcSEcCtD
Risedronate—Dermatitis—Etoposide—sarcoma	8.78e-05	0.0011	CcSEcCtD
Risedronate—Headache—Etoposide—sarcoma	8.73e-05	0.00109	CcSEcCtD
Risedronate—Flatulence—Doxorubicin—sarcoma	8.73e-05	0.00109	CcSEcCtD
Risedronate—Vertigo—Epirubicin—sarcoma	8.6e-05	0.00108	CcSEcCtD
Risedronate—Syncope—Epirubicin—sarcoma	8.59e-05	0.00107	CcSEcCtD
Risedronate—Back pain—Doxorubicin—sarcoma	8.57e-05	0.00107	CcSEcCtD
Risedronate—Muscle spasms—Doxorubicin—sarcoma	8.52e-05	0.00106	CcSEcCtD
Risedronate—Loss of consciousness—Epirubicin—sarcoma	8.42e-05	0.00105	CcSEcCtD
Risedronate—Cough—Epirubicin—sarcoma	8.36e-05	0.00104	CcSEcCtD
Risedronate—Nausea—Etoposide—sarcoma	8.28e-05	0.00103	CcSEcCtD
Risedronate—Hypertension—Epirubicin—sarcoma	8.27e-05	0.00103	CcSEcCtD
Risedronate—Anaemia—Doxorubicin—sarcoma	8.19e-05	0.00102	CcSEcCtD
Risedronate—Chest pain—Epirubicin—sarcoma	8.15e-05	0.00102	CcSEcCtD
Risedronate—Myalgia—Epirubicin—sarcoma	8.15e-05	0.00102	CcSEcCtD
Risedronate—Arthralgia—Epirubicin—sarcoma	8.15e-05	0.00102	CcSEcCtD
Risedronate—Anxiety—Epirubicin—sarcoma	8.12e-05	0.00102	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—sarcoma	8.1e-05	0.00101	CcSEcCtD
Risedronate—Dry mouth—Epirubicin—sarcoma	7.97e-05	0.000996	CcSEcCtD
Risedronate—Vertigo—Doxorubicin—sarcoma	7.96e-05	0.000995	CcSEcCtD
Risedronate—Syncope—Doxorubicin—sarcoma	7.95e-05	0.000993	CcSEcCtD
Risedronate—Loss of consciousness—Doxorubicin—sarcoma	7.79e-05	0.000973	CcSEcCtD
Risedronate—Infection—Epirubicin—sarcoma	7.76e-05	0.00097	CcSEcCtD
Risedronate—Cough—Doxorubicin—sarcoma	7.73e-05	0.000966	CcSEcCtD
Risedronate—Shock—Epirubicin—sarcoma	7.69e-05	0.000961	CcSEcCtD
Risedronate—Nervous system disorder—Epirubicin—sarcoma	7.66e-05	0.000958	CcSEcCtD
Risedronate—Hypertension—Doxorubicin—sarcoma	7.65e-05	0.000956	CcSEcCtD
Risedronate—Skin disorder—Epirubicin—sarcoma	7.59e-05	0.000949	CcSEcCtD
Risedronate—Chest pain—Doxorubicin—sarcoma	7.54e-05	0.000943	CcSEcCtD
Risedronate—Arthralgia—Doxorubicin—sarcoma	7.54e-05	0.000943	CcSEcCtD
Risedronate—Myalgia—Doxorubicin—sarcoma	7.54e-05	0.000943	CcSEcCtD
Risedronate—Anxiety—Doxorubicin—sarcoma	7.52e-05	0.000939	CcSEcCtD
Risedronate—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—sarcoma	7.49e-05	0.000936	CcSEcCtD
Risedronate—Dry mouth—Doxorubicin—sarcoma	7.38e-05	0.000922	CcSEcCtD
Risedronate—Infection—Doxorubicin—sarcoma	7.18e-05	0.000898	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Epirubicin—sarcoma	7.12e-05	0.00089	CcSEcCtD
Risedronate—Shock—Doxorubicin—sarcoma	7.11e-05	0.000889	CcSEcCtD
Risedronate—Nervous system disorder—Doxorubicin—sarcoma	7.09e-05	0.000886	CcSEcCtD
Risedronate—Insomnia—Epirubicin—sarcoma	7.07e-05	0.000883	CcSEcCtD
Risedronate—Skin disorder—Doxorubicin—sarcoma	7.02e-05	0.000878	CcSEcCtD
Risedronate—Paraesthesia—Epirubicin—sarcoma	7.02e-05	0.000877	CcSEcCtD
Risedronate—Dyspnoea—Epirubicin—sarcoma	6.97e-05	0.000871	CcSEcCtD
Risedronate—Dyspepsia—Epirubicin—sarcoma	6.88e-05	0.00086	CcSEcCtD
Risedronate—Gastrointestinal disorder—Epirubicin—sarcoma	6.75e-05	0.000843	CcSEcCtD
Risedronate—Fatigue—Epirubicin—sarcoma	6.74e-05	0.000842	CcSEcCtD
Risedronate—Pain—Epirubicin—sarcoma	6.68e-05	0.000835	CcSEcCtD
Risedronate—Constipation—Epirubicin—sarcoma	6.68e-05	0.000835	CcSEcCtD
Risedronate—Musculoskeletal discomfort—Doxorubicin—sarcoma	6.59e-05	0.000823	CcSEcCtD
Risedronate—Insomnia—Doxorubicin—sarcoma	6.54e-05	0.000817	CcSEcCtD
Risedronate—Paraesthesia—Doxorubicin—sarcoma	6.49e-05	0.000812	CcSEcCtD
Risedronate—Dyspnoea—Doxorubicin—sarcoma	6.45e-05	0.000806	CcSEcCtD
Risedronate—Gastrointestinal pain—Epirubicin—sarcoma	6.39e-05	0.000799	CcSEcCtD
Risedronate—Dyspepsia—Doxorubicin—sarcoma	6.37e-05	0.000796	CcSEcCtD
Risedronate—Gastrointestinal disorder—Doxorubicin—sarcoma	6.24e-05	0.00078	CcSEcCtD
Risedronate—Fatigue—Doxorubicin—sarcoma	6.23e-05	0.000779	CcSEcCtD
Risedronate—Urticaria—Epirubicin—sarcoma	6.21e-05	0.000776	CcSEcCtD
Risedronate—Constipation—Doxorubicin—sarcoma	6.18e-05	0.000773	CcSEcCtD
Risedronate—Pain—Doxorubicin—sarcoma	6.18e-05	0.000773	CcSEcCtD
Risedronate—Abdominal pain—Epirubicin—sarcoma	6.18e-05	0.000772	CcSEcCtD
Risedronate—Body temperature increased—Epirubicin—sarcoma	6.18e-05	0.000772	CcSEcCtD
Risedronate—Gastrointestinal pain—Doxorubicin—sarcoma	5.91e-05	0.000739	CcSEcCtD
Risedronate—Hypersensitivity—Epirubicin—sarcoma	5.76e-05	0.00072	CcSEcCtD
Risedronate—Urticaria—Doxorubicin—sarcoma	5.74e-05	0.000718	CcSEcCtD
Risedronate—Body temperature increased—Doxorubicin—sarcoma	5.72e-05	0.000714	CcSEcCtD
Risedronate—Abdominal pain—Doxorubicin—sarcoma	5.72e-05	0.000714	CcSEcCtD
Risedronate—Asthenia—Epirubicin—sarcoma	5.61e-05	0.000701	CcSEcCtD
Risedronate—Pruritus—Epirubicin—sarcoma	5.53e-05	0.000691	CcSEcCtD
Risedronate—Diarrhoea—Epirubicin—sarcoma	5.35e-05	0.000668	CcSEcCtD
Risedronate—Hypersensitivity—Doxorubicin—sarcoma	5.33e-05	0.000666	CcSEcCtD
Risedronate—Asthenia—Doxorubicin—sarcoma	5.19e-05	0.000648	CcSEcCtD
Risedronate—Dizziness—Epirubicin—sarcoma	5.17e-05	0.000646	CcSEcCtD
Risedronate—Pruritus—Doxorubicin—sarcoma	5.12e-05	0.000639	CcSEcCtD
Risedronate—Vomiting—Epirubicin—sarcoma	4.97e-05	0.000621	CcSEcCtD
Risedronate—Diarrhoea—Doxorubicin—sarcoma	4.95e-05	0.000618	CcSEcCtD
Risedronate—Rash—Epirubicin—sarcoma	4.93e-05	0.000616	CcSEcCtD
Risedronate—Dermatitis—Epirubicin—sarcoma	4.92e-05	0.000615	CcSEcCtD
Risedronate—Headache—Epirubicin—sarcoma	4.9e-05	0.000612	CcSEcCtD
Risedronate—Dizziness—Doxorubicin—sarcoma	4.78e-05	0.000598	CcSEcCtD
Risedronate—Nausea—Epirubicin—sarcoma	4.64e-05	0.00058	CcSEcCtD
Risedronate—Vomiting—Doxorubicin—sarcoma	4.6e-05	0.000575	CcSEcCtD
Risedronate—Rash—Doxorubicin—sarcoma	4.56e-05	0.00057	CcSEcCtD
Risedronate—Dermatitis—Doxorubicin—sarcoma	4.56e-05	0.000569	CcSEcCtD
Risedronate—Headache—Doxorubicin—sarcoma	4.53e-05	0.000566	CcSEcCtD
Risedronate—Nausea—Doxorubicin—sarcoma	4.3e-05	0.000537	CcSEcCtD
